بدائل البحث:
decrease » increase (توسيع البحث)
يعرض 1 - 20 نتائج من 56 نتيجة بحث عن '(( significant amount decrease ) OR ( significant positive breast ))', وقت الاستعلام: 0.10s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome حسب Faruk Skenderi (6616190)

    منشور في 2022
    "…HER2+/APO tumors tend to have a less aggressive phenotype and a more favorable outcome despite a markedly lower ER/PR positivity.</p><h2>Other Information</h2> <p> Published in: Breast Cancer Research and Treatment<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s10549-022-06578-4" target="_blank">http://dx.doi.org/10.1007/s10549-022-06578-4</a></p>…"
  4. 4

    Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positiv... حسب Dimassi, Hani

    منشور في 2009
    "…The status of the axillary lymph nodes in nonmetastatic lymph node-positive breast cancer (BC) patients remains the single most important determinant of overall survival (OS). …"
    احصل على النص الكامل
    احصل على النص الكامل
    article
  5. 5

    Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer حسب Rasha M. Sareyeldin (18131371)

    منشور في 2019
    "…Despite the anti-HER2 and cytotoxic chemotherapy, HER2 subtype is an aggressive disease with significant mortality. Recent advances in molecular biology techniques, including gene expression profiling, proteomics, and microRNA analysis, have been extensively used to explore the underlying mechanisms behind human breast carcinogenesis and metastasis including HER2-positive breast cancer, paving the way for developing new targeted therapies. …"
  6. 6

    Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways حسب Hadeel Kheraldine (14231609)

    منشور في 2024
    "…</p><h3>Conclusion</h3><p dir="ltr">Our findings implicate that a combination of DA and BMS-202 could have a significant impact on the management of HER2-positive breast cancer.…"
  7. 7

    Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways حسب Hadeel Kheraldine (14231609)

    منشور في 2021
    "…<p>HER2-positive breast cancer is one of its most challenging subtypes, forming around 15–25% of the total cases. …"
  8. 8
  9. 9
  10. 10

    Discrimination of breast cancer from benign tumours using Raman spectroscopy حسب Fiona M. Lyng (2189614)

    منشور في 2019
    "…Breast cancer is diagnosed by histopathological examination of breast biopsy material but this is subjective and relies on morphological changes in the tissue. …"
  11. 11
  12. 12

    Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy حسب Fiona M. Lyng (2189614)

    منشور في 2019
    "…<p dir="ltr">Correction to: Discrimination of breast cancer from benign tumours using Raman spectroscopy. …"
  13. 13

    Diagnostic test accuracy of AI-assisted mammography for breast imaging: a narrative review حسب Daksh Dave (17949239)

    منشور في 2025
    "…The motivation for this research lies in addressing the need for enhanced diagnostic tools in breast cancer screening, where early detection can significantly impact patient outcomes. …"
  14. 14

    Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma حسب Peter Kubatka (11008854)

    منشور في 2020
    "…In conclusion, sumac demonstrated significant oncostatic activities in rodent models of breast carcinoma that were validated by mechanistic studies in vivo and in vitro.…"
  15. 15

    Imaging Patterns in Breast Cancer for Women Under 40 Years: A Descriptive Cohort Study حسب Amal A. Alhaidary (21633410)

    منشور في 2024
    "…Out of the 73 patients who underwent genetic tests, 32.9% tested positive for gene mutations. No statistically significant correlation was found between specific age groups and breast composition (<i>P</i> = 0.216), specific mammogram abnormalities such as masses (<i>P</i> = 0.262), or microcalcifications (<i>P</i>= 0.421). …"
  16. 16
  17. 17

    Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer حسب Andrea Remo (447375)

    منشور في 2015
    "…The expression pattern of the most significant MRs was then evaluated by immunohistochemistry (IHC) in two independent cohorts of IBCs (n = 39) and nIBCs (n = 82) and normal breast tissues (n = 15) spotted on tissue microarrays. …"
  18. 18

    CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors حسب Mashael Al-toub (3563303)

    منشور في 2022
    "…Interestingly, significant positive correlation between CXCR7 and CXCL12 gene expression (Pearson = 0.3, p = 2.0 × 10–16) was observed in breast cancer patients, suggesting a biological role for the CXCR7/CXCL12 genetic circuit in breast cancer biology. …"
  19. 19

    Breast Cancer Screening Practices in a Tertiary Care Center in the State of Qatar: A Cross-Sectional Survey حسب Jessiya Veliyankodan Parambil (16518660)

    منشور في 2021
    "…While the attitude towards breast cancer screening is positive, the overall compliance with the national recommendations is sub-optimal. …"
  20. 20

    Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients حسب Ali Abouelghar (14152773)

    منشور في 2018
    "…In addition, the favorable prognostic influence of NK-activating ligands’ upregulation, as a whole, was mainly significantly associated with HER2-positive and basal-like subtypes, lymph node positive phenotype, and high-grade tumors.…"